Composite colloidal gels based on host-guest interactions and their preparation methods

By grafting β-cyclodextrin and adamantane derivatives onto the surface of gelatin nanospheres to form a composite colloidal gel, the problems of mechanical strength and tolerance to physiological saline environments of colloidal gels were solved, and a colloidal gel with high mechanical strength and self-healing ability was achieved, which is suitable for biomedical applications.

CN119101262BActive Publication Date: 2026-11-10EAST CHINA UNIV OF SCI & TECH +1
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411242309.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-05
Publication Date
2026-11-10
Estimated Expiration
2044-09-05

AI Technical Summary

Technical Problem

Existing colloidal gels have poor mechanical strength and are difficult to tolerate physiological saline environments, which limits their application in biomedicine.

Method used

By grafting β-cyclodextrin and adamantane derivatives onto the surface of gelatin nanospheres, a composite colloidal gel with high mechanical strength and self-healing ability is formed by utilizing host-guest interactions. Combined with a crosslinking agent preparation method, this results in a composite colloidal gel.

Benefits of technology

The prepared composite colloidal gel has high mechanical strength, excellent self-healing ability, biodegradability and biocompatibility, and can maintain good performance in physiological saline environment, making it suitable for the biomedical field.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119101262B_ABST
    Figure CN119101262B_ABST
Patent Text Reader

Abstract

This invention discloses a composite colloidal gel based on host-guest interaction and its preparation method. The specific preparation steps involve grafting a host (β-cyclodextrin) and a guest (adamantane) onto the surface of gelatin nanospheres via an amide reaction to obtain β-cyclodextrin gelatin nanospheres and aadamantane gelatin nanospheres, respectively. These nanospheres are then uniformly mixed, and the resulting mixture is centrifuged to ensure sufficient contact and reaction between the host and guest. After removing the supernatant, the β-cyclodextrin gelatin nanosphere / adamantane gelatin nanosphere composite colloidal gel is obtained. This method is simple and has high production efficiency. The resulting composite colloidal gel exhibits high mechanical strength, excellent self-healing ability, injectability, biodegradability, and biocompatibility. It can withstand physiological saline environments, which is beneficial for its application in the biomedical field. Furthermore, it demonstrates good self-healing ability and high mechanical strength in physiological saline, surfactant, and serum environments.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of nanomaterials, specifically relating to a composite colloidal gel based on host-guest interaction and its preparation method. Background Technology

[0002] Colloidal gels are gel material systems with microscopic network structures built upon micron or nano colloidal particles as basic structural units through physical or chemical interactions between the particles. They are widely used in biomedical engineering, 3D printing materials, and cosmetics. Unlike traditional polymer gels, colloidal gels are formed through non-covalent forces between colloidal particles. When this interaction is reversible, colloidal gels exhibit excellent self-healing capabilities; that is, under destructive shear forces, colloidal gels exhibit liquid-like fluidity, and when the external force is removed, the material automatically restores its mechanical strength. This unique rheological behavior makes these self-healing colloidal gels highly valuable in tissue engineering and regenerative medicine.

[0003] Although the special rheological behavior of colloidal gels makes them quite valuable for applications, there are still two problems that need to be solved in this type of material system: (1) Colloidal gels constructed by reversible weak forces generally have poor mechanical strength; (2) Colloidal gels constructed by forces such as electrostatic interaction or coordination of metal ion ligands are difficult to tolerate physiological salt environment, which seriously limits their application in biomedical environment. Summary of the Invention

[0004] The purpose of this invention is to address the aforementioned shortcomings of existing colloidal gels by providing a composite colloidal gel based on host-guest interactions, which has high mechanical strength, excellent self-healing ability, tolerance to physiological saline environments, good degradability and biocompatibility, as well as its preparation method.

[0005] To achieve the above objectives, the technical solution adopted by the present invention is as follows:

[0006] The first aspect of this invention is to provide a method for preparing a composite colloidal gel based on host-guest interactions, comprising the following steps:

[0007] S1: Gelatin nanospheres with carboxyl groups on their surface were prepared into a gelatin nanosphere suspension. Then, an amino-containing β-cyclodextrin derivative was added to the gelatin nanosphere suspension, mixed and stirred evenly, and then a crosslinking agent was added and stirred at room temperature. The reaction product was purified by dialysis and freeze-dried to obtain β-cyclodextrin gelatin nanosphere powder.

[0008] S2: Gelatin nanospheres with carboxyl groups on their surface were prepared into a gelatin nanosphere suspension. Then, an amino-containing adamantane derivative was added to the gelatin nanosphere suspension, mixed and stirred evenly, and then a crosslinking agent was added and stirred at room temperature. The reaction product was purified by dialysis and freeze-dried to obtain adamantane gelatin nanosphere powder.

[0009] S3: Weigh appropriate amounts of β-cyclodextrin gelatin nanosphere powder and adamantane gelatin nanosphere powder, and dissolve them in solvents to form β-cyclodextrin gelatin nanosphere suspension and adamantane gelatin nanosphere suspension, respectively.

[0010] S4: Mix the β-cyclodextrin gelatin nanosphere suspension and the adamantane gelatin nanosphere suspension in an appropriate ratio to obtain a uniformly dispersed colloidal suspension; after centrifuging the colloidal suspension and removing the supernatant, a composite colloidal gel is obtained.

[0011] According to the present invention, in steps S1 and S2, the concentration of the gelatin nanosphere suspension is 5 mg / mL to 20 mg / mL, and the pH is 4 to 7; the content of carboxyl groups in the gelatin nanospheres is 0.06 mmol / g to 0.10 mmol / g.

[0012] According to the present invention, in steps S1 and S2, the amino-containing β-cyclodextrin derivative is ethylenediamine β-cyclodextrin, peramino β-cyclodextrin, or mono-6-O-amino-β-cyclodextrin, preferably ethylenediamine β-cyclodextrin; the amino-containing adamantane derivative is adamantaneamine hydrochloride, adamantane methylamine hydrochloride, adamantane ethylamine hydrochloride, or adamantaneamidine hydrochloride, preferably adamantaneamine hydrochloride.

[0013] According to the present invention, in step S1, the molar ratio of the amino-containing β-cyclodextrin derivative to the carboxyl groups contained in the gelatin nanospheres is 0.5:1 to 10:1; the molar ratio of the crosslinking agent to the carboxyl groups contained in the gelatin nanospheres is 1:1 to 10:1.

[0014] According to the present invention, in step S2, the molar ratio of the amino-containing adamantane derivative to the carboxyl groups contained in the gelatin nanospheres is 0.5:1 to 10:1; the molar ratio of the crosslinking agent to the carboxyl groups contained in the gelatin nanospheres is 1:1 to 10:1.

[0015] According to the present invention, in steps S1 and S2, the crosslinking agent is selected from one or more of 4-(4,6-dimethoxytriazine-2-yl)-4-methylmorpholine hydrochloride, carbodiimide and N-hydroxysuccinimide.

[0016] According to the present invention, in step S3, the solvent is deionized water, an aqueous solution containing 150 mM sodium chloride, a Tween 20 aqueous solution with a volume concentration of 1%, or a culture medium containing 10% fetal bovine serum.

[0017] According to the present invention, in step S4, the mass concentration of the colloidal suspension is 5% to 30%; the mass ratio of adamantane gelatin nanospheres to β-cyclodextrin gelatin nanospheres in the colloidal suspension is 0.2 to 5, preferably 1.

[0018] According to the present invention, in step S4, the relative centrifugal force of the colloidal suspension during centrifugation is 5000–15000 g. -1 Preferably 9000-13000g -1 The centrifugation time is 5 to 30 minutes, preferably 10 to 20 minutes.

[0019] A second aspect of the present invention is to provide a composite colloidal gel prepared by the above-described preparation method.

[0020] The beneficial effects of this invention are as follows:

[0021] 1. The composite colloidal gel of the present invention is constructed by the interaction between two types of gelatin nanoparticles, one with a host (β-cyclodextrin) grafted on the surface and the other with a guest (adamantane) grafted on the surface. It has high mechanical strength, excellent self-healing ability, injectability, biodegradability and biocompatibility. The resulting composite colloidal gel has an elastic modulus higher than 10 kPa, a self-healing efficiency ≥100%, and can still maintain a certain mechanical strength after injection.

[0022] 2. Compared with colloidal gels constructed by electrostatic interaction and coordination of metal ligands, the composite colloidal gel of the present invention can withstand physiological saline environment, which is beneficial to its application in the biomedical field; it has good self-healing ability and high mechanical strength in physiological saline environment, surfactant environment and serum environment.

[0023] 3. The preparation method of the present invention is simple and has high production efficiency. Furthermore, the preparation principle is applicable to similar composite colloidal gel systems, providing a design scheme for the development of this large class of materials. Attached Figure Description

[0024] Figure 1 This is an experimental schematic diagram of the formation of composite colloidal gel in this invention (the inset is a photograph of the sample after gelation).

[0025] Figure 2 A through 2C are transmission electron microscope images of gelatin nanospheres, adamantane gelatin nanospheres, and β-cyclodextrin gelatin nanospheres from Example 1, respectively. Scale bar = 1. .

[0026] Figure 3 The values ​​represent the changes in elastic modulus (G') and viscous modulus (G") over time during the gelation of β-cyclodextrin gelatin nanospheres and adamantane gelatin nanosphere colloidal suspensions at room temperature.

[0027] Figure 4 This describes the self-healing behavior of the β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel prepared in Example 1.

[0028] Figure 5 The self-healing behavior of β-cyclodextrin gelatin nanospheres / adamantine gelatin nanosphere composite colloidal gels prepared under different relative centrifugal forces is described.

[0029] Figure 6 The self-healing behavior of β-cyclodextrin gelatin nanospheres / adamantine gelatin nanosphere composite colloidal gels prepared by centrifugation at different colloidal suspension concentrations is described.

[0030] Figure 7 The self-healing behavior of β-cyclodextrin gelatin nanospheres / adamantine gelatin nanosphere composite colloidal gels prepared by centrifugation at different two-phase particle mass ratios is described.

[0031] Figure 8 This describes the self-repairing behavior of the β-cyclodextrin gelatin nanosphere / adamantine gelatin nanosphere composite colloidal gel in a physiological saline environment.

[0032] Figure 9 This describes the self-healing behavior of the β-cyclodextrin gelatin nanosphere / adamantine gelatin nanosphere composite colloidal gel in a surfactant environment.

[0033] Figure 10 This describes the self-repairing behavior of the β-cyclodextrin gelatin nanosphere / adamantine gelatin nanosphere composite colloidal gel in a serum environment.

[0034] Figure 11 It is the injectability of the β-cyclodextrin gelatin nanosphere / adamantine gelatin nanosphere composite colloidal gel.

[0035] Figure 12 It is the cytotoxicity of β-cyclodextrin gelatin nanospheres / adamantine gelatin nanosphere composite colloidal gel.

[0036] Figure 13 It is the biocompatibility of the β-cyclodextrin gelatin nanosphere / adamantane gelatin nanosphere composite colloidal gel. Detailed Implementation

[0037] The technical solution of the present invention will be clearly and completely described below with reference to the accompanying drawings and specific embodiments. It should be understood that the following embodiments are only a part of the embodiments of the present invention, and not all of them. All other embodiments obtained by those skilled in the art based on the embodiments of the present invention without creative effort are within the scope of the present invention.

[0038] Unless otherwise specified, all reagents used in the following examples are commercially available products. The gelatin nanospheres with carboxyl groups on their surface were prepared using a conventional solvent removal method in the following examples, preferably with a carboxyl group content of 0.06–0.1 mmol / g.

[0039] like Figure 1 As shown, in this invention, the host (β-cyclodextrin) and the guest (adamantane) are grafted onto the surface of gelatin nanospheres via an amide reaction to obtain β-cyclodextrin gelatin nanospheres and adamantane gelatin nanospheres. The two are then uniformly blended and the resulting mixture is centrifuged to ensure full contact between the host and the guest, thereby forming a uniform composite colloidal gel network.

[0040] Example 1

[0041] (1) Preparation of gelatin nanospheres:

[0042] Gelatin nanospheres were first prepared by a solvent removal method. The resulting gelatin nanospheres had a particle size of approximately 380 nm, and their surface Zeta potential was measured to be approximately -7 mV in a 5 mM HEPES aqueous solution (pH 7.4). The carboxyl group content of the gelatin nanospheres was 0.08 mmol / g. The morphology of the gelatin nanospheres is as follows. Figure 2 As shown in Figure A.

[0043] (2) Preparation of adamantane gelatin nanospheres:

[0044] 1 g of gelatin nanospheres were dispersed in 100 mL of deionized water to obtain a 10 mg / mL gelatin nanosphere suspension. The pH of the suspension was adjusted to 6–7. 0.45 g of adamantane hydrochloride was weighed and added to the suspension, and the mixture was stirred thoroughly to obtain a homogeneous solution. 0.33 g of 4-(4,6-dimethoxytriazine-2-yl)-4-methylmorpholine hydrochloride (crosslinking agent) was weighed and added to the mixture, and the reaction was stirred for 3 days. After dialysis purification of the product in ultrapure water using a dialysis bag with a molecular weight cutoff of 8k–14k, the particle size of the adamantane-grafted gelatin nanospheres was measured to be approximately 400 nm, and the surface Zeta potential was approximately +4.5 mV in a 5 mM HEPES aqueous solution at pH 7.4. The surface morphology is as follows. Figure 2 As shown in B.

[0045] (3) Preparation of β-cyclodextrin gelatin nanospheres:

[0046] 1 g of gelatin nanospheres were dispersed in 100 mL of deionized water to obtain a 10 mg / mL gelatin nanosphere suspension. The pH of the suspension was adjusted to 6–7. 2.82 g of ethylenediamine β-cyclodextrin was weighed and added to the suspension, and the mixture was stirred thoroughly to obtain a homogeneous solution. 0.33 g of 4-(4,6-dimethoxytriazine-2-yl)-4-methylmorpholine hydrochloride (crosslinking agent) was weighed and added to the mixture, and the reaction was stirred for 3 days. After dialysis purification of the product in ultrapure water using a dialysis bag with a molecular weight cutoff of 8k–14k, the particle size of the β-cyclodextrin-grafted gelatin nanospheres was measured to be approximately 390 nm, and the surface Zeta potential was approximately +8 mV in a 5 mM HEPES aqueous solution at pH 7.4. The surface morphology is as follows. Figure 2 As shown in C.

[0047] (4) Preparation of β-cyclodextrin gelatin nanospheres / adamantane gelatin nanosphere composite colloidal gel

[0048] A certain amount of the adamantane gelatin nanospheres and β-cyclodextrin gelatin nanospheres prepared in steps (2) and (3) above were dispersed in deionized water to prepare a colloidal particle suspension with a mass concentration of 20% for each phase. The two phases were directly mixed and quickly stirred until homogeneous to obtain a colloidal suspension in which the two phases of colloidal particles were uniformly mixed. The mass concentration of the colloidal suspension was still 20%, and the mass ratio of the two phases of colloidal particles, that is, the mass ratio of β-cyclodextrin gelatin nanospheres to adamantane gelatin nanospheres, was 1. The colloidal suspension was then subjected to a 11000g... -1 Centrifuge for 20 minutes, then remove the supernatant with a pipette to obtain the β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel.

[0049] The gelation process was detected using a rheometer, and the results were as follows: Figure 3 The changes in elastic modulus (G') and viscous modulus (G") of the colloidal suspension over time during gelation at room temperature are shown.

[0050] Depend on Figure 3 The results show that at room temperature, the two-phase colloidal particles rapidly self-assemble to form a gel network. The elastic modulus (G') intersects with the viscous modulus (G") in a very short time and remains higher than the viscous modulus (G) thereafter. The intersection point is the turning point of the colloidal dispersion from a liquid fluid to a solid gel, thus confirming the rapid formation of the gel.

[0051] Example 2

[0052] This embodiment is basically the same as that of embodiment 1, except that the crosslinking agents in steps (2) and (3) are 0.15g carbodiimide and 0.09g N-hydroxysuccinimide; finally, β-cyclodextrin gelatin nanospheres / adamantane gelatin nanospheres composite colloidal gel are obtained.

[0053] Among them, the adamantane gelatin nanospheres prepared in step (2) were found to have a particle size of about 380 nm, a surface zeta potential of about +3.2 mV in 5 mM HEPES aqueous solution at pH 7.4, and a grafting rate of 0.039 mmol / g; the β-cyclodextrin gelatin nanospheres prepared in step (3) were found to have a particle size of about 375 nm, a surface zeta potential of about +6.1 mV in 5 mM HEPES aqueous solution at pH 7.4, and a grafting rate of 0.045 mmol / g.

[0054] Examples 3-8

[0055] Examples 3-8 are basically the same as Example 1, except that the concentration of the gelatin nanosphere suspension, the molar ratio of ethylenediamine β-cyclodextrin / gelatin nanosphere carboxyl content, the molar ratio of adamantane hydrochloride / gelatin nanosphere carboxyl content, and the molar ratio of crosslinking agent / gelatin nanosphere carboxyl content in steps (2) and (3) are set in Tables 1 and 2 below; finally, a β-cyclodextrin gelatin nanosphere / adamantane gelatin nanosphere composite colloidal gel is obtained.

[0056] As shown in Tables 1 and 2, in steps (2) and (3), by changing the concentration of the gelatin nanosphere suspension, the molar ratio of ethylenediamine β-cyclodextrin / gelatin nanosphere carboxyl content, the molar ratio of adamantane hydrochloride / gelatin nanosphere carboxyl content, or the molar ratio of crosslinking agent / gelatin nanosphere carboxyl content, adamantane gelatin nanospheres with different particle sizes and different grafting rates can be obtained.

[0057] Table 1. Particle size and grafting ratio of adamantane gelatin nanospheres prepared in Examples 3-8

[0058]

[0059] Table 2. Particle size and grafting rate of β-cyclodextrin gelatin nanospheres prepared in Examples 3-8

[0060]

[0061] Example 9

[0062] In this embodiment, the preparation method of the β-cyclodextrin gelatin nanospheres / adamantane gelatin nanospheres composite colloidal gel is basically the same as that in Example 1, except that in step (4), the colloidal suspension is placed in 5000g of water. -1 Centrifuge for 20 min to obtain β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel.

[0063] Example 10

[0064] In this embodiment, the preparation method of the β-cyclodextrin gelatin nanospheres / adamantane gelatin nanospheres composite colloidal gel is basically the same as that in Example 1, except that in step (4), the colloidal suspension is placed in 9000g of water. -1 Centrifuge for 20 min to obtain β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel.

[0065] Example 11

[0066] In this embodiment, the preparation method of the β-cyclodextrin gelatin nanospheres / adamantane gelatin nanospheres composite colloidal gel is basically the same as that in Example 1, except that in step (4), the colloidal suspension is heated in 13000g of water. -1 Centrifuge for 20 min to obtain β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel.

[0067] Example 12

[0068] In this embodiment, the preparation method of the β-cyclodextrin gelatin nanospheres / adamantane gelatin nanospheres composite colloidal gel is basically the same as that in Example 1, except that in step (4), the colloidal suspension is heated to 11000g -1 Centrifuge for 5 min to obtain β-cyclodextrin gelatin nanospheres / adamantine gelatin nanosphere composite colloidal gel.

[0069] Example 13

[0070] In this embodiment, the preparation method of the β-cyclodextrin gelatin nanospheres / adamantane gelatin nanospheres composite colloidal gel is basically the same as that in Example 1, except that in step (4), the colloidal suspension is heated to 11000g -1 Centrifuge for 10 min to obtain β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel.

[0071] Example 14

[0072] In this embodiment, the preparation method of the β-cyclodextrin gelatin nanospheres / adamantane gelatin nanospheres composite colloidal gel is basically the same as that in Example 1, except that in step (4), the colloidal suspension is heated to 11000g -1 Centrifuge for 15 min to obtain a β-cyclodextrin gelatin nanosphere / adamantine gelatin nanosphere composite colloidal gel.

[0073] Example 15

[0074] In this embodiment, the preparation method of the β-cyclodextrin gelatin nanospheres / adamantane gelatin nanospheres composite colloidal gel is basically the same as that in Example 1, except that in step (4), the colloidal suspension is heated to 11000g -1Centrifuge for 25 min to obtain β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel.

[0075] Example 16

[0076] In this embodiment, the preparation method of the β-cyclodextrin gelatin nanospheres / adamantane gelatin nanospheres composite colloidal gel is basically the same as that in Example 1, except that in step (4), the colloidal suspension is heated to 11000g -1 Centrifuge for 30 min to obtain β-cyclodextrin gelatin nanospheres / adamantine gelatin nanosphere composite colloidal gel.

[0077] Example 17

[0078] In this embodiment, the preparation method of β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel is basically the same as that in Example 1, except that the mass concentration of colloidal particles in the colloidal suspension in step (4) is 15%; finally, β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel is obtained.

[0079] Example 18

[0080] In this embodiment, the preparation method of β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel is basically the same as that in Example 1, except that the mass concentration of colloidal particles in the colloidal suspension in step (4) is 25%; finally, β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel is obtained.

[0081] Example 19

[0082] In this embodiment, the preparation method of β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel is basically the same as that in Example 1. The difference is that the mass concentration of colloidal particles in the colloidal suspension in step (4) is 30%; and finally, β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel is obtained.

[0083] Example 20

[0084] In this embodiment, the preparation method of the β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel is basically the same as that in Example 1. The difference is that in step (4), the mixing ratio of the two phase particles is the mass ratio of the two phase particles: β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres = 0.2; and finally, the β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel is obtained.

[0085] Example 21

[0086] In this embodiment, the preparation method of β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel is basically the same as that in Example 1. The difference is that in step (4), the mixing ratio of the two phase particles is the mass ratio of the two phase particles: β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres = 5; finally, β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel is obtained.

[0087] Example 22

[0088] In this embodiment, the preparation method of the β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel is basically the same as that in Example 1. The difference is that in step (4), the adamantine gelatin nanospheres and β-cyclodextrin gelatin nanospheres prepared in Example 1 are dispersed in a 150 mM NaCl salt solution to prepare a colloidal particle suspension with a mass concentration of 20% for each particle. Finally, the β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel is obtained.

[0089] Example 23

[0090] In this embodiment, the preparation method of the β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel is basically the same as that in Example 1. The difference is that in step (4), the adamantine gelatin nanospheres and β-cyclodextrin gelatin nanospheres prepared in Example 1 are dispersed in a Tween20 aqueous solution with a volume concentration of 1% to prepare a colloidal particle suspension with a mass concentration of 20% for each particle. Finally, the β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel is obtained.

[0091] Example 24

[0092] In this embodiment, the preparation method of the β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel is basically the same as that in Example 1. The difference is that in step (4), the adamantine gelatin nanospheres and β-cyclodextrin gelatin nanospheres prepared in Example 1 are dispersed in a culture medium containing 10% fetal bovine serum to prepare a colloidal particle suspension with a mass concentration of 20% for each particle. Finally, the β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel is obtained.

[0093] Self-healing behavior of the β-cyclodextrin gelatin nanospheres / adamantine gelatin nanosphere composite colloidal gel prepared in Example 25 and Example 1.

[0094] The self-healing behavior of the composite colloidal gel obtained in Example 1 was tested using a rheometer. The specific test method is as follows: First, a time-vibration scan was performed, and an external force with a frequency of 1 Hz and a strain of 0.5% was applied to the sample. The elastic modulus (G') and viscous modulus (G”) of the sample were then tested. The G' value at this stage is the initial elastic modulus of the sample. Subsequently, the applied strain was gradually increased from 0.1% to 1000%. During this process, the applied external force destroyed the sample, and the elastic modulus (G') gradually decreased, eventually falling below the viscous modulus (G”). That is, the colloidal system transformed from a rigid solid to a viscous fluid, and the gel structure was destroyed. Subsequently, the external force was removed, and the recovery of the sample's elastic modulus (G') was examined. The percentage of the recovered elastic modulus to the initial elastic modulus was defined as the self-healing efficiency of the gel. The test results are as follows: Figure 4 As shown.

[0095] Depend on Figure 4 The results show that the β-cyclodextrin gelatin nanospheres / adamantane gelatin nanospheres composite colloidal gel possesses excellent self-healing ability. The gel's elastic modulus rapidly recovers after shear damage, and the repaired elastic modulus is higher than the initial elastic modulus, demonstrating a self-healing efficiency exceeding 100%. Furthermore, this self-healing behavior can occur repeatedly; the elastic modulus recovers rapidly after multiple shear cycles are applied to the sample.

[0096] Under low shear stress, the elastic modulus (G') of the composite colloidal gel is higher than the viscous modulus (G") and remains stable, indicating that the gel exhibits rigid solid behavior. Then, as the shear stress is gradually increased (strain from 0.1% to 1000%), the elastic modulus (G') gradually decreases and eventually falls below the viscous modulus (G"), disrupting the network structure of the surface gel and transforming it from a solid to a viscous fluid. After the destructive shear stress on the gel is removed, the elastic modulus of the gel recovers rapidly, even slightly exceeding the initial elastic modulus, and this self-healing behavior is repeatable.

[0097] Example 26

[0098] The self-healing behavior of the β-cyclodextrin gelatin nanospheres / adamantine gelatin nanosphere composite colloidal gels obtained in Examples 9-24 was tested using a rheometer, following the test method of Example 25. Specific test results are as follows:

[0099] (1) Self-healing behavior of composite colloidal gels prepared under different relative centrifugal forces

[0100] The self-healing behavior of β-cyclodextrin gelatin nanospheres / adamantane gelatin nanosphere composite colloidal gels prepared under different relative centrifugal forces in Examples 9-11 and Example 1 is as follows: Figure 5 As shown.

[0101] Depend on Figure 5The results show that the β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gels exhibit excellent self-healing capabilities under different relative centrifugal forces, with self-healing efficiencies reaching or even exceeding 100%. Under lower relative centrifugal forces, the host (β-cyclodextrin) and guest (adamantine) cannot fully contact and react, failing to form a uniformly dispersed network structure, resulting in a lower elastic modulus of the gel.

[0102] (2) Self-healing behavior of composite colloidal gels prepared at different centrifugation times

[0103] The self-healing behavior of the β-cyclodextrin gelatin nanospheres / adamantane gelatin nanospheres composite colloidal gels prepared in Examples 12-16 and Example 1 at different relative centrifugation times is as follows:

[0104] As centrifugation time increases, the elastic modulus and viscous modulus of the composite colloidal gel increase until after 20 minutes, at which point further increases in centrifugation time cease to increase the elastic modulus. At shorter centrifugation times, the host (β-cyclodextrin) and guest (adamantane) cannot fully contact and react, failing to form a uniformly dispersed network structure, resulting in a lower elastic modulus of the gel. After a certain time, the host (β-cyclodextrin) and guest (adamantane) fully contact and react, and thereafter, further increases in centrifugation time cannot improve the elastic modulus of the composite colloidal gel.

[0105] (3) Self-healing behavior of composite colloidal gels prepared at different colloidal suspension concentrations

[0106] The self-healing behavior of β-cyclodextrin gelatin nanospheres / adamantane gelatin nanosphere composite colloidal gels prepared in Examples 17-19 and Example 1 at different colloidal suspension concentrations is as follows: Figure 6 As shown.

[0107] Depend on Figure 6 The results show that, regardless of the mass concentration of the colloidal suspension, the elastic modulus and viscous modulus of the composite colloidal gel obtained after centrifugation are basically the same. Under sufficient relative centrifugal force and centrifugation time, the host (β-cyclodextrin) and guest (adamantane) come into full contact and react, forming a uniform network structure. Different mass concentrations of colloidal suspensions do not affect the final composite colloidal gel.

[0108] (4) Self-healing behavior of composite colloidal gels prepared under different two-phase particle mass ratios

[0109] The self-healing behavior of β-cyclodextrin gelatin nanospheres / adamantane gelatin nanosphere composite colloidal gels prepared in Examples 20-21 and Example 1 at different two-phase particle mass ratios is as follows: Figure 7 As shown.

[0110] Depend on Figure 7The results show that when the mass ratio of adamantane gelatin nanospheres to β-cyclodextrin gelatin nanospheres is greater than 1, the elastic modulus (G') of the composite colloidal gel is low, and the self-healing efficiency is also low. When the mass ratio is less than or equal to 1, both the elastic modulus (G') and the self-healing efficiency are high. When the mass ratio of adamantane gelatin nanospheres to β-cyclodextrin gelatin nanospheres is large, the number of host molecules (β-cyclodextrin) is less than that of guest molecules (adamantane), resulting in insufficient bonding and an imperfect colloidal network structure. When the mass ratio of adamantane gelatin nanospheres to β-cyclodextrin gelatin nanospheres reaches 1, the number of host molecules (β-cyclodextrin) is similar to or exceeds that of guest molecules (adamantane), enabling sufficient bonding and forming a uniformly dispersed colloidal gel network.

[0111] (5) Self-healing behavior of composite colloidal gels prepared under different environments

[0112] Examples 22-24 illustrate the self-healing ability of β-cyclodextrin gelatin nanospheres / adamantine gelatin nanosphere composite colloidal gels prepared under different environments. Figures 8-10 As shown, the self-repair efficiency of the β-cyclodextrin gelatin nanosphere / adamantane gelatin nanosphere composite colloidal gel in multiple shear failure cycles under different environments is as follows: Figures 8-10 As shown.

[0113] Depend on Figures 8-10 The results show that the β-cyclodextrin gelatin nanospheres / adamantane gelatin nanospheres composite colloidal gel has excellent self-healing ability in physiological saline environment, surfactant environment and serum environment. The elastic modulus of this composite colloidal gel recovers rapidly after being sheared and damaged.

[0114] As shown in Table 3, the self-healing efficiency of this composite gel can still reach 90% in a physiological saline environment, reach or even exceed 100% in a surfactant environment, and reach or even exceed 95% in a serum environment. Furthermore, this self-repairing behavior can occur repeatedly, and its elastic modulus can be rapidly recovered after multiple shear cycles are applied to the sample. This demonstrates that the composite colloidal gel of this invention possesses excellent self-healing ability and high mechanical strength in physiological saline, surfactant, and serum environments.

[0115] Table 3. β-cyclodextrin gelatin nanospheres / adamantine gelatin nanosphere composite colloidal gels under different environments

[0116] Self-healing efficiency in a self-healing cycle after multiple rounds of shear failure

[0117]

[0118] Example 27: Injectability of β-cyclodextrin gelatin nanospheres / adamantane gelatin nanosphere composite colloidal gel

[0119] The β-cyclodextrin gelatin nanospheres / adamantane gelatin nanospheres composite colloidal gel prepared in Example 24 was injected using a common medical syringe. The injection effect was as follows: Figure 11 As shown.

[0120] Depend on Figure 11 The results show that the β-cyclodextrin gelatin nanospheres / adamantane gelatin nanospheres composite colloidal gel prepared by the method of the present invention has good injectability and can be molded by extrusion.

[0121] Example 28: Biocompatibility of β-cyclodextrin gelatin nanospheres / adamantane gelatin nanosphere composite colloidal gel.

[0122] The gelatin nanospheres, adamantane gelatin nanospheres, β-cyclodextrin gelatin nanospheres, and β-cyclodextrin gelatin nanosphere / adamantane gelatin nanosphere composite colloidal gels prepared in Example 1 were dispersed in deionized water to obtain uniformly dispersed suspensions.

[0123] The biocompatibility of this composite colloidal gel was investigated through in vitro cell experiments. The specific steps were as follows:

[0124] (I) Cell Culture

[0125] Taking HUVEC cell culture as an example, the cells are cultured in growth medium (DMEM containing 10% fetal bovine serum (FBS, Gibco)) at 37°C, 95% relative humidity, and 5% CO2. The cell culture medium is changed every three days. Before use, the cells are washed with phosphate-buffered saline (PBS), separated with trypsin / EDTA solution (0.25% trypsin / 0.02% EDTA) for 1 minute, and then resuspended in the culture medium for use.

[0126] (II) CCK8 assay for determining the cytotoxicity of materials

[0127] The cell suspension prepared in step (I) was seeded into 96-well plates at a cell concentration of 5000 cells / well. After static incubation for 24 hours, gelatin nanospheres, adamantane gelatin nanospheres, β-cyclodextrin gelatin nanospheres, and β-cyclodextrin gelatin nanosphere / adamantane gelatin nanosphere suspensions were added to the 96-well plates at different concentrations. A blank control group was also set up. After 24 hours, the culture medium was replaced and CCK8 solution was added for co-culturing. After 4 hours, the absorbance at 450 nm was measured using a microplate reader to obtain the cytotoxicity of different materials. The results are as follows: Figure 12 As shown.

[0128] Depend on Figure 12The results showed that gelatin nanospheres exhibited slight cytotoxicity at high concentrations, while adamantane gelatin nanospheres reduced cytotoxicity, and β-cyclodextrin gelatin nanospheres were completely non-cytotoxic. Furthermore, the composite colloidal gel of the two was also completely non-cytotoxic.

[0129] (III) Live / Dead Fluorescence Assay (LIVE / DEAD assay) to determine the biocompatibility of materials

[0130] The cell suspension prepared in step I was seeded into 6-well plates at a cell concentration of 4*10^5 cells / well. After static incubation for 24 hours, gelatin nanospheres, adamantane gelatin nanospheres, β-cyclodextrin gelatin nanospheres, and a β-cyclodextrin gelatin nanosphere / adamantane gelatin nanosphere composite colloidal gel suspension were added at a concentration of 35 mg / mL and co-cultured with the cells for 24 hours. Before staining, the cells were washed three times with sterile PBS. At room temperature, 2 mM calcein (green fluorescent labeling for live cells) and 3 mM ethidium homodimer (red fluorescent labeling for dead cells) were added, and the results were observed using a fluorescence microscope. Figure 13 As shown.

[0131] Depend on Figure 13 The results showed that the β-cyclodextrin gelatin nanospheres / adamantine gelatin nanospheres composite colloidal gel had good biocompatibility and no cytotoxicity.

[0132] The technical solution of the present invention has been described in detail above through specific embodiments. However, it is worth noting that, under the inventive concept of this application, various equivalent changes, modifications or substitutions are obvious to those skilled in the art and should be covered within the protection scope of this application.

Claims

1. A method for preparing composite colloidal gels based on host-guest interactions, characterized in that, Includes the following steps: S1: Gelatin nanospheres with carboxyl groups on their surface were prepared into a gelatin nanosphere suspension. Then, an amino-containing β-cyclodextrin derivative was added to the gelatin nanosphere suspension, mixed and stirred evenly, and then a crosslinking agent was added and stirred at room temperature. The reaction product was purified by dialysis and freeze-dried to obtain β-cyclodextrin gelatin nanosphere powder. S2: Gelatin nanospheres with carboxyl groups on their surface were prepared into a gelatin nanosphere suspension. Then, an amino-containing adamantane derivative was added to the gelatin nanosphere suspension, mixed and stirred evenly, and then a crosslinking agent was added and stirred at room temperature. The reaction product was purified by dialysis and freeze-dried to obtain adamantane gelatin nanosphere powder. S3: Weigh appropriate amounts of β-cyclodextrin gelatin nanosphere powder and adamantane gelatin nanosphere powder, and dissolve them in solvents to form β-cyclodextrin gelatin nanosphere suspensions and adamantane gelatin nanosphere suspensions, respectively; the solvent is deionized water, an aqueous solution containing 150 mM sodium chloride, a 1% Tween 20 aqueous solution, or a culture medium containing 10% fetal bovine serum; S4: Mix the β-cyclodextrin gelatin nanosphere suspension and the adamantane gelatin nanosphere suspension in an appropriate ratio to obtain a uniformly dispersed colloidal suspension; centrifuge the colloidal suspension and remove the supernatant to obtain a composite colloidal gel; the relative centrifugal force of the colloidal suspension during centrifugation is 11000-15000g. -1 The centrifugation time is 20-30 minutes.

2. The method for preparing a composite colloidal gel based on host-guest interaction according to claim 1, characterized in that, In steps S1 and S2, the concentration of the gelatin nanosphere suspension is 5 mg / mL to 20 mg / mL, and the pH is 4 to 7; the content of carboxyl groups in the gelatin nanospheres is 0.06 mmol / g to 0.10 mmol / g.

3. The method for preparing a composite colloidal gel based on host-guest interaction according to claim 1, characterized in that, In steps S1 and S2, the amino-containing β-cyclodextrin derivative is ethylenediamine β-cyclodextrin, peramino β-cyclodextrin, or mono-6-O-amino-β-cyclodextrin; the amino-containing adamantane derivative is adamantaneamine hydrochloride, adamantane methylamine hydrochloride, adamantane ethylamine hydrochloride, or adamantaneamidine hydrochloride.

4. The method for preparing a composite colloidal gel based on host-guest interaction according to claim 1, characterized in that, In step S1, the molar ratio of the amino-containing β-cyclodextrin derivative to the carboxyl groups contained in the gelatin nanospheres is 0.5:1 to 10:1; the molar ratio of the crosslinking agent to the carboxyl groups contained in the gelatin nanospheres is 1:1 to 10:

1.

5. The method for preparing a composite colloidal gel based on host-guest interaction according to claim 1, characterized in that, In step S2, the molar ratio of the amino-containing adamantane derivative to the carboxyl groups contained in the gelatin nanospheres is 0.5:1 to 10:1; the molar ratio of the crosslinking agent to the carboxyl groups contained in the gelatin nanospheres is 1:1 to 10:

1.

6. The method for preparing a composite colloidal gel based on host-guest interaction according to claim 1, characterized in that, In steps S1 and S2, the crosslinking agent is selected from one or more of 4-(4,6-dimethoxytriazine-2-yl)-4-methylmorpholine hydrochloride, carbodiimide, and N-hydroxysuccinimide.

7. The method for preparing a composite colloidal gel based on host-guest interaction according to claim 1, characterized in that, In step S4, the mass concentration of the colloidal suspension is 5% to 30%; the mass ratio of adamantane gelatin nanospheres to β-cyclodextrin gelatin nanospheres in the colloidal suspension is 0.2 to 5.

8. A composite colloidal gel based on host-guest interactions, characterized in that, The composite colloidal gel is prepared by the preparation method according to any one of claims 1 to 7.

Citation Information

Patent Citations

  • Structural protein / hyaluronic acid composite micro-nano particle, particle hydrogel material and application

    CN115521627A

  • Self-adaptive self-healing hydrogel as well as preparation method and application thereof

    CN118546393A